GTEx Uterus 20-29 vs 60-69 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Uterus 20-29 vs 60-69 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Uterus 20-29 vs 60-69 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Uterus 20-29 vs 60-69 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Uterus 20-29 vs 60-69 Down.

Results found

Linked to

 

Label

Description

 

Gene

urothelial cancer associated 1

Gene

MIR3142 host gene

Gene

napsin B aspartic peptidase (pseudogene)

Gene

SPATA31 subfamily C member 2

Gene

sialic acid binding Ig like lectin 17, pseudogene

Gene

KIF23 and PAQR5 antisense RNA 1

Gene

long intergenic non-protein coding RNA 2015

Gene

long intergenic non-protein coding RNA 595

Gene

GREM1 antisense RNA 1

Gene

collagen type VI alpha 4 pseudogene 1

  • Gene

    urothelial cancer associated 1



  • Gene

    napsin B aspartic peptidase (pseudogene)


  • Gene

    SPATA31 subfamily C member 2


  • Gene

    sialic acid binding Ig like lectin 17, pseudogene


  • Gene

    KIF23 and PAQR5 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 2015


  • Gene

    long intergenic non-protein coding RNA 595


  • Gene

    GREM1 antisense RNA 1


  • Gene

    collagen type VI alpha 4 pseudogene 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.